Still looks like momo day traders to me - again - boom in Robinhood traders chart | RGLS Message Board Posts

Regulus Therapeutics Inc.

  RGLS website

RGLS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  595 of 603  at  6/22/2020 7:25:31 AM  by

Dendrimer


 In response to msg 594 by  Steve_382
view thread

Re: Still looks like momo day traders to me - again - boom in Robinhood traders chart

I know nothing about charts, but the Alport drug, now called SAR339375 by Sanofi, is still progressing in a clinical trial. In March they opened a new study site in the UK, and in April, they added the INN name for the drug: lademirsen.
 
In my experience, companies only go to the bother of getting an INN if they are planning taking the drug forward into pivotal trials.
 
Relevance for RGLS is that they are due $10M when an interim recruitment milestone is reached in this trial, and potentially another $30M at the end of phase 2 – I guess some of this is dependent on taking the drug forward at this point.
 
Covid must have slowed (the already very slow!) recruitment, so maybe the share price increase is due to the INN being seen as increasing the chances of RGLS getting that $30M further down the line.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 45
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
596 Re: Still looks like momo day traders to me - again - boom in Robinhood traders chart arthurs1 0 7/9/2020 6:17:17 PM
597 Re: Study of SAR339375 in Patients With Alport Syndrome (HERA) - Changes Steve_382 3 7/10/2020 8:04:45 AM






Financial Market Data provided by
.


Loading...